U.S. Paper and Forestry Products Stock News

Trip.com Group stock has delivered an 86.1% gain over the past 5 years, yet the broader valuation checks still suggest the shares lean cheap. Recent share price weakness in 2026 leaves investors weighing that longer term return against a high value score and mixed shorter term performance. Over 5 years, Trip.com Group is up 86.1%, which points to meaningful value creation for longer term holders despite recent setbacks. The 2025 Sustainability Report and the new US$100 million Tourism...

Douglas Elliman slipped 0.6% to US$1.78 after its second quarter report, a muted move for a stock tied to luxury housing sentiment. The headline is not the price; it is the sharp improvement in the income statement. Revenue was US$283.4m and the quarterly loss narrowed to US$2.7m. For a brokerage that only recently turned profitable on a trailing basis, that combination turns today’s dip into a sentiment check rather than a clear verdict. The rest of the report shows how fragile or durable...

In the second quarter of 2026, Upbound Group, Inc. reported sales of US$903.7 million, revenue of US$1.16 billion, and net income of US$21.58 million, with basic earnings per share from continuing operations of US$0.37, all modestly higher than a year earlier. The company also narrowed its full-year 2026 consolidated revenue outlook to US$4.70–US$4.85 billion and issued third-quarter revenue guidance of US$1.05–US$1.15 billion, giving investors a clearer view of expected scale and earnings...

A surprise loss of 23,000 US jobs in July and softer wage growth has put resilience back in the spotlight. Healthcare giants in areas such as pharmaceuticals and medical equipment are often watched closely when the broader economy looks less certain, because demand for many treatments can remain steady. This article reveals 3 large healthcare stocks from our screener that appear well placed against this backdrop. The three stocks highlighted below are just a sample from this theme, with the...

Karman Holdings (KRMN) drew investor attention on 6 August 2026 after reporting second quarter earnings, raising full year revenue guidance to between US$730 million and US$745 million, and amending its credit facility. See our latest analysis for Karman Holdings. The strong second quarter report, raised guidance and lower financing costs have been met with a sharp swing in sentiment toward Karman Holdings. The 1 day share price return is 5.6% and the 7 day share price return is 20.9%...

Regulatory milestone puts focus on GRAIL stock GRAIL (GRAL) is in the spotlight after the FDA scheduled a September 23, 2026 advisory committee meeting to review the Premarket Approval application for its Galleri multi cancer early detection blood test. See our latest analysis for GRAIL. The FDA panel date has come alongside GRAIL’s recent Q2 update and a sharp 1 day share price return of 9.59%, even though the year to date share price return is down 21.82%. Over the past year, the total...

Newsmax stock focus after recent trading performance Newsmax (NMAX) has drawn attention after recent trading, with the stock closing at $8.97 on 6 August 2026. Short term moves included a 4.79% gain over the past day and 16.34% over the past week. See our latest analysis for Newsmax. For context, Newsmax’s recent momentum has been strong, with a 90 day share price return of 40.60% and a year to date share price return of 13.83%, even though the 1 year total shareholder return declined...

Biglari Holdings stock barely flinched after earnings, easing just 0.3%, yet the headline result was anything but quiet. A swing to basic earnings per share of US$158.17 for the quarter, alongside net income of US$39.93 million, marks a sharp break from the recent run of losses. The market still treats Biglari as an unprofitable story with stretched valuation, which sets up a sentiment clash between the trailing weakness and a powerful single quarter of profitability. Is Biglari Holdings now...

Essent Group stock jumped 4.9% to US$68.72 after earnings, a strong move for a mortgage insurer that investors usually treat as a slow compounder rather than a trading vehicle. The headline is simple: profitability held up and the balance sheet stayed thick with capital even as net profit margin over the past year sat at 51.5%, below the earlier 56.4% level investors had grown used to. Short term traders see a pop. Long term holders see a company earning US$2.09 per share this quarter while...

In late July 2026, Align Technology reported second-quarter 2026 results showing sales rising to US$1,056.19 million year-on-year, issued softer sequential revenue guidance for the third quarter, and outlined the impact of one-time restructuring, depreciation, and legal charges on its GAAP operating margin outlook. At the same time, after discussions with Elliott Investment Management, Align committed to appoint three new independent directors, launched a comprehensive strategic and...

With the Iran war disrupting the Strait of Hormuz, inflation staying stubbornly high and rate hikes still on the table, many investors are questioning how much risk is really baked into today’s lofty valuations. Periods like this can punish fragile business models but also reveal sturdier ones. This article focuses on 3 large cap value stocks that screens suggest are more exposed to these shocks, and explains what that could mean for your portfolio decisions. The three stocks below are only a...

In early August 2026, Perma-Fix Environmental Services announced it had formed a partnership with Mirion Technologies under the SBA Mentor-Protégé Program to jointly pursue U.S. Department of Energy nuclear cleanup and advanced waste characterization projects. This collaboration pairs Perma-Fix’s nuclear waste treatment and remediation capabilities with Mirion’s radiation detection and measurement expertise, potentially deepening Mirion’s role in long-duration federal cleanup work. We’ll now...

FIGS stock has delivered a very strong 129.3% return over the past year, yet its valuation checks still suggest the shares are not an obvious bargain. Recent optimism around growth and profitability now sits alongside a low overall value score and an assessment that the stock screens as overvalued on market multiples. The 129.3% one year return signals that expectations around FIGS have shifted quickly and that recent buyers are paying a much higher price than they were a year ago. Stronger...

Ferguson Enterprises Inc. recently announced that its Board of Directors declared a quarterly dividend of US$0.89 per share, payable on October 7, 2026, to shareholders of record as of August 21, 2026, with a September 10, 2026 currency election deadline for Depositary Interest holders. Alongside this dividend, Ferguson has been added to the S&P 500 and multiple related S&P indices, a shift that can influence how index funds and institutional investors position the stock within diversified...

In the second quarter of 2026, Biogen Inc. reported revenue of US$2,736.0 million, up from US$2,645.5 million a year earlier, while net income fell to US$97.5 million and diluted earnings per share from continuing operations declined to US$0.66 from US$4.33. Despite higher sales and revenue, Biogen’s earnings compressed significantly, even as its newer therapies outpaced its legacy multiple sclerosis portfolio and the Apellis acquisition expanded its growth product lineup. We’ll now examine...

Why Manhattan Associates Stock Is Back In Focus Manhattan Associates (MANH) has jumped back onto investor watchlists after a golden cross pattern coincided with fresh 2026 earnings guidance and an updated read on recent quarterly results. This mix of technical and fundamental news gives you several angles to assess the stock. Recent guidance, the latest earnings report and ongoing capital allocation moves all feed into how you might think about risk and reward here. See our latest analysis...

TOMS Capital’s no confidence campaign against Voya Financial (VOYA) has moved into a new phase, with a definitive proxy filing and an open letter challenging the board’s decisions, recent execution, and approach to potential third party interest. See our latest analysis for Voya Financial. At a share price of US$101.40, Voya Financial has delivered a 26.54% 90 day share price return and a 46.36% 1 year total shareholder return. This suggests recent momentum has been strong despite the fresh...

D.R. Horton stock has delivered a 62.8% gain over the past five years, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and earnings multiples currently point to the shares trading below what those frameworks suggest as fair. Over the last five years, D.R. Horton has returned 62.8%, which means long term holders have already seen solid value creation even before considering today’s valuation signals. Market expectations for future housing demand and construction activity can...

ANI Pharmaceuticals just took a 5.3% hit in a single session, yet the earnings story looks more like growing pains than a broken thesis. You have a stock that came into the print soft over the past month, then sold off again right after reporting adjusted earnings per share of US$2.21 on revenue of US$266.0m. The real swing factor is profit quality. Investors appear to be wrestling with how much of the recent profitability and trailing US$259.6m of adjusted EBITDA reflects repeatable rare...

Why APA earnings and guidance matter for investors now APA (APA) reported second quarter 2026 results on 5 August, with earnings per share above analyst expectations even as revenue was lower than a year ago. The company also raised U.S. oil production guidance, increased its 2026 cost savings target, and reaffirmed plans for shareholder returns and future exploration. These announcements give you several concrete data points to weigh. You can compare reported revenue and profit to your...

Embecta entered this quarter wearing the label of a deeply discounted diabetes device stock, with a single digit P/E and significant balance sheet questions. The market lifted the share price 26% to US$4.42 in the first session after earnings. The move reflects one headline takeaway: the business reported a sharp rebound in both revenue and profit, with Q3 sales of US$271.7m and net income of US$21.1m after a loss in Q2. For a company under pressure over debt and cash generation, that...

How PayPal's Latest Earnings Set the Stage for Investors PayPal Holdings (PYPL) just reported second quarter 2026 results, with sales of US$8.68b and net income of US$1.10b, giving investors a mixed update on growth and profitability. Sales for the first half of 2026 reached US$17.04b, while net income for the same period came in at US$2.22b. Earnings per share from continuing operations were lower than a year ago on both a basic and diluted basis. At the same time, PayPal Holdings (PYPL)...

In late July 2026, Laureate Education, Inc. reported second-quarter sales of US$615.86 million and net income of US$137.1 million, alongside higher first-half earnings and an updated full-year 2026 revenue outlook of US$1.92 billion to US$1.93 billion, implying 13% as-reported growth. At the same time, Laureate expanded its share repurchase effort, having already bought back 13,863,000 shares for US$399.61 million and adding a further US$250 million authorization, highlighting management’s...

In early August 2026, IonQ reported record second-quarter sales of US$80.05 million, raised its full-year 2026 revenue outlook to US$280–290 million, and secured a US$28 million DARPA contract extension to deliver 125 Evergreen-05 optical atomic clocks for mission-critical U.S. government applications while committing US$15 million to expand production capacity. Together with new federal collaborations in quantum communications and security, these developments highlight IonQ’s growing role...